Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus

Veterinary Microbiology

Volumn 116, Issue 1-3, 2006, Pages 53-59

  Chávez, Juliana H ^a   Leal, Paulo C ^b   Yunes, Rosendo A ^b   Nunes, Ricardo J ^b   Barardi, Célia R M ^c   Pinto, Aguinaldo R ^a   Simões, Cláudia M O ^c   Zanetti, Carlos R ^a  

^a CCB   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c CCS   (Brazil)

Author keywords

Anti rabies activity; Cytopathic viral effect inhibition; Cytotoxicity; Phenolic compounds; Rabies virus

Indexed keywords

2,3,4 TRIHYDROXYACETOPHENONE; 3,4,5 TRIMETHOXYBENZOIC ACID; 3,4,5 TRIMETHOXYBENZOIC ACID ETHYL ESTER; 4 METHOXYACETOPHENONE; CATECHIN; DECYL GALLATE; DODECYL GALLATE; EPICATECHIN; EPIGALOCATECHIN; GALLIC ACID; GALLIC ACID BUTYL ESTER; GALLIC ACID CETYL ESTER; GALLIC ACID ETHYL ESTER; GALLIC ACID METHYL ESTER; GALLIC ACID OCTYL ESTER; GALLIC ACID PROPYL ESTER; HEPTYL GALLATE; HEXYL GALLATE; KETAMINE; METHISOPRINOL; OCTADECYL GALLATE; PENTYL GALLATE; PHENOL DERIVATIVE; PHLOROGLUCINOL; QUERCETIN; TETRADECYL GALLATE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; IN VITRO STUDY; NONHUMAN; RABIES VIRUS; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; MICE; MOLECULAR STRUCTURE; PHENOLS; RABIES VIRUS;

RABIES VIRUS;

EID: 33746296779     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.03.019     Document Type: Article

References (42)

1. Ahn M.J., Kim C.Y., Lee J.S., Kim T.J., Kim S.H., Lee C.K., Lee B.B., Shin C.G., Huh H., and Kim J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med. 68 (2002) 457-459
2. Arya S.C. Failures of post-exposure rabies and other immunotherapies in developing countries. Vaccine 7 (1989) 372
3. Bunyapraphatsara N., Dechsree S., Yoosook C., Herunsalee A., and Panpisutchai Y. Anti-herpes simplex virus component isolated from Maclura cochinchinensis. Phytomedicine 6 (2000) 421-424
4. Center for Disease Control and Prevention, 1999. Human rabies prevention-United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 48, 1-21.
5. Chamorro C., Perez-Perez M.J., Rodriguez-Barrios F., Gago F., De Clercq E., Balzarini J., San-Felix A., and Camarasa M.J. Exploring the role of the 5′-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivatives. Antiviral Res. 50 (2001) 207-222
6. Chiang L.C., Chiang W., Chang M.Y., Ng L.T., and Lin C.C. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 55 (2002) 53-62
7. Consales C.A., Mendonça R.Z., Gallina N.M., and Pereira R.A. Cythopathic effect induced by rabies virus in McCoy cells. J. Virol. Methods 27 (1990) 277-285
8. Eisenbrand G., Pool-Zobel B., Baker V., Balls M., Blaauboer B.J., Boobis A., Carere A., Kevekordes S., Lhuguenot J.C., Pieters R., and Kleiner J. Methods of in vitro toxicology. Food Chem. Toxicol. 40 (2002) 193-236
9. Hendekli C.M. Current therapies in rabies. Arch. Virol. 150 (2005) 1047-1057
10. Hernández-Jáuregui P., González-Vega D., Cruz-Lavín E., and Hernández-Baumgarten E. In vitro effect of isoprinosine on rabies virus. Am. J. Vet. Res. 41 (1980) 1475-1478
11. Jackson A.C., Warrell M.J., Rupprecht C.E., Ertl H.C., Dietzschold B., O'Reilly M., Leach R.P., Fu Z.F., Wunner W.H., Bleck T.P., and Wilde H. Management of rabies in humans. Clin. Infect. Dis. 36 1 (2002) 60-63
12. Kane C.J.M., Menna J.H., Sung C.C., and Yeh Y.C. Methyl gallate, methyl-3,4,5-trihydroxy-benzoate, is a potent and highly specific inhibitor of herpes simplex virus in vitro. II. Antiviral activity of methyl gallate and its derivatives. Biosci. Rep. 8 (1988) 95-101
13. King A. Cell culture of rabies virus. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), World Health Organization, Geneva 114-130
14. Liu Y., Peterson D.A., Kimura H., and Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69 (1997) 581-593
15. Lockhart B.P., Tordo N., and Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with dissociative anesthetic ketamine. Antimicrob. Agents Chemother. 36 (1992) 1750-1755
16. Madhusudana S.N., Paul J.P.V., Abhilash V.K., and Suja M.S. Rapid diagnosis of rabies in humans and animals by a blot enzyme immunoassay. Int. J. Infect. Dis. 8 (2004) 339-345
17. Madhusudana S.N., Shamsundar R., and Seetharaman S. In vitro inactivation of the rabies virus by ascorbic acid. Int. J. Infect. Dis. 8 (2004) 21-25
18. Marcheti M., Mastromarino P., Rieti S., Seganti L., and Orsi N. Inhibition of herpes simplex, rabies and rubella viruses by lecitins with different specificities. Res. Virol. 146 (1995) 211-215
19. Matsuo M., Sasaki N., Saga K., and Kaneko T. Cytotoxicity of flavonoids toward culture normal human cells. Biol. Pharm. Bull. 28 (2005) 253-259
20. Meerbach A., Neyts J., Balzarini J., Helbig B., De Clercq E., and Wutzler P. In vitro activity of polyhydroxycarboxylates against herpesviruses and HIV. Antiviral Chem. Chemother. 12 (2001) 337-345
21. Ministério da Saúde, 2005. Secretaria de Vigilância em Saúde. Raiva humana transmitida por morcegos no estado do Pará e Maranhão. 25/10/2005. Available at: http://www.portal.saude.gov.br/portal/arquivos/pdf/nota_raiva.pdf (accessed on 11/08/05).
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
23. Nogueira Y.L. Rabies in McCoy cell line. Part I. Cytopathic effect and replication. Rev. Inst. Adolfo Lutz. 52 (1992) 9-16
24. Nogueira Y.L., and Amaral C.F.C. Rabies in McCoy cell line. Part II. Titration. Rev. Inst. Adolfo Lutz. 52 (1992) 17-21
25. Pietropaolo V., Seganti L., Marchetti M., Sinibaldi L., Orsi N., and Nicoletti R. Effect of natural and semysynthetic polymers on rabies virus infection in CER cells. Res. Virol. 144 (1993) 151-158
26. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27 (1938) 493-497
27. Rupprecht C.E., Halon C.A., and Hemachudha T. Rabies re-examined. Lancet Infect. Dis. 2 (2002) 327-343
28. Savi L.A., Leal P.C., Vieira T.O., Rosso R., Nunes R.J., Yunes R.A., Pasa-Creczynski T.B., Barardi C.R.M., and Simões C.M.O. Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid. Arzneimittelforschung 55 (2005) 66-75
29. Serkedjieva J., and Hay A.J. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antiviral Res. 37 (1998) 121-130
30. Serkedjieva J. Combined antiinfluenza virus activity of Flos verbasci infusion and amantadine derivatives. Phytother. Res. 14 (2000) 571-574
31. 50-values and cell survival. Eur. J. Clin. Chem. Clin. Biochem. 33 (1995) 813-823
32. Simões C.M.O., Amoros M., and Girre L. Mechanisms of antiviral activity of triterpenoid saponins. Phytother. Res. 21 (1999) 317-325
33. Smee D.F., Morrison A.C., Barnard D.L., and Sidwell R.W. Comparison of colorimetric, fluorimetric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. J. Virol. Methods 106 (2002) 71-79
34. Srinivasan A., Burton E.C., Kuehnert M.J., Rupprecht C.E., Sutker W.L., and Kiazek T.G. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med. 352 (2005) 1103-1111
35. Takeuchi H., Baba M., and Shigeta S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J. Virol. Methods 33 (1991) 61-71
36. Tillekeratne L.M.V., Sherette A., Fulmer J.A., Hupe L., Hupe D., Gabarra S., Peliska J.A., and Hudson R.A. Differential inhibition of polymerase and strand-transfer activities of HIV-1 reverse transcriptase. Bioorg. Méd. Chem. Lett. 12 (2002) 525-528
37. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., and Boyd M.R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51 (1991) 2515-2520
38. Willoughby Jr. R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., and Rupprecht C.E. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352 (2005) 2508-2514
39. Wiktor T.J., and Clark H. Chronic rabies virus infection of cell culture. Infect. Immun. 6 (1972) 988-995
40. World Health Organization, 2005. Rabies incidence. Available at: http://www.who.int/rabies/epidemiology/en/ (accessed on 01/12/05).
41. Wunner W.H. Rabies virus. In: Jackson A.C., and Wunner H. (Eds). Rabies (2002), Academic Press, New York 1-22
42. Yamamoto K., Kitano T., Arai Y.T., Yoshii K., Hasobe M., and Saneyoshi M. Inhibitory effect of a new antibiotic, guanine 7-N-oxide, on the replication of several RNA viruses. Antiviral Res. 14 (1990) 173-178